PGT-A vs PGT-M: Which Technology is Better for Ensuring a Healthy Pregnancy in 2026?
Expert Contributor
Dr. Olivia Bennett, Reproductive and Family Building Expert
I am Dr. Olivia Bennett, a medical writer and fertility consultant specializing in surrogacy, egg freezing, IVF, and family building education. Over the past decade, I have assisted over 500 families in achieving healthy births through precise genetic screening technologies. I understand the nuances between PGT-A and PGT-M in clinical applications and their decisive impact on success rates.
In the field of assisted reproduction in 2026, intended parents often hesitate between PGT-A and PGT-M. This guide is for those who wish to avoid genetic risks and increase live birth rates through top-tier US laboratory technology. The conclusion is: If you want to increase the success rate of pregnancy at an advanced age and exclude chromosomal abnormalities, choose PGT-A; if you or your family carry specific genetic disease genes, PGT-M is a must.
What are PGT-A and PGT-M?
PGT-A (Preimplantation Genetic Testing for Aneuploidies), formerly known as PGS, It primarily tests embryos for normal number and structure of all 23 chromosome pairs. It ensures the embryo does not have extra or missing chromosomes (such as Down syndrome), selecting the healthy embryo with the most developmental potential for transfer, significantly increasing pregnancy rates and reducing miscarriage risks.
PGT-M (Preimplantation Genetic Testing for Monogenic/Single Gene Defects), formerly known as PGD, is a precision strike against specific single-gene hereditary diseases. It specifically screens whether the embryo carries pathogenic genes known to the parents (such as Thalassemia or Spinal Muscular Atrophy), ensuring that family genetic diseases are blocked from being passed to the next generation.
Verdict (Quick Advice)
- Choose PGT-A if... You are of advanced maternal age (over 35), have a history of recurrent miscarriages, or want to maximize the success rate of a single transfer through gender selection and chromosomal screening.
- Choose PGT-M if... You or your partner are known carriers of a single-gene hereditary disease, or there is a clear family history of genetic diseases requiring precise blocking.
- Choose both if... You carry genetic genes and also belong to an advanced age group or wish to ensure embryo chromosomal euploidy for double protection.
Core Trade-off: PGT-A focuses on the macro health of "quantity and structure," while PGT-M focuses on the micro diagnosis of "specific genes."
Quick Comparison Table
| Core Advantages | Main Limitations | Cost (RSMC) | Target Audience | Expert Review |
|---|---|---|---|---|
| Comprehensive screening of 23 pairs of chromosomes | Cannot detect single-gene mutations | $5,000 (includes 15 embryos) | Most IVF families | The "Gold Standard" for increasing live birth rates |
| Precisely blocks 160+ genetic diseases | Requires custom probes in advance, time-consuming | Approx. $7,800/single gene | Known gene carriers | The terminator of family genetic diseases |
PGT-A Overview
What is PGT-A: This technology screens for chromosomal aneuploidy before embryo implantation, ensuring the transferred embryo has the correct number of chromosomes.
Advantages:
- Significantly reduces miscarriage rates caused by chromosomal abnormalities (RSMC frozen embryo transfer live birth rate reaches 69%).
- Accurately identifies embryo gender to meet family balancing needs.
- Excludes common chromosomal diseases such as Down syndrome (Trisomy 21) and Edwards syndrome (Trisomy 18).
- Shortens the time required to achieve a successful pregnancy and reduces ineffective transfers.
PGT-M Overview
What is PGT-M: Genetic diagnosis for single-gene diseases, identifying embryos carrying specific pathogenic genes through embryo biopsy.
Advantages:
- Can detect over 160 genetic diseases including Thalassemia, Cystic Fibrosis, and Hemophilia.
- Provides the only guarantee for families with a serious history of genetic diseases to have healthy offspring.
- RSMC provides customized probe services to ensure extremely high diagnostic precision.
Feature-by-Feature Comparison
Setup & Learning Curve
Preparation for PGT-A is relatively simple; you only need to determine the testing intention before the stimulation cycle. PGT-M requires intended parents to provide detailed genetic testing reports and sometimes DNA samples from family members to construct a genetic map (probe creation).
Core Workflows
PGT-A Workflow
Blastocyst culture to day 5-7 -> Trophectoderm cell biopsy -> NGS sequencing -> Results in 1-2 weeks.
PGT-M Workflow
Probe creation -> Blastocyst biopsy -> Targeted gene amplification and comparison -> Results in 2-3 weeks.
Automation & Reliability
RSMC has a CAP+CLIA dual-certified laboratory using the most advanced automated sequencing platforms. PGT-A has a very high degree of automation; PGT-M relies more on the experience of embryologists to design precise diagnostic plans.
Pricing Comparison
| Testing Item | Base Fee | Inclusions/Notes |
|---|---|---|
| PGT-A (PGS) | $5,000 | Includes up to 15 embryos; $250/each additional |
| PGT-M (PGD) | $7,800 | Screening for a single specific gene mutation |
| NIPT | $850 | Double insurance testing after 10 weeks of pregnancy |
Best Fit by Persona
Women of Advanced Maternal Age (35+): Choose PGT-A
As age increases, the rate of egg chromosomal abnormalities surges. PGT-A is key to ensuring embryo quality and avoiding miscarriage.
Families Carrying Genetic Diseases: Choose PGT-M
If you are a known carrier of a pathogenic gene, PGT-M is the only scientific means to ensure your child is no longer troubled by the same disease.
FAQs
Can PGT-A and PGT-M be done at the same time?
Absolutely. For women of advanced maternal age with a history of genetic diseases, we strongly recommend performing both. RSMC's laboratory can complete both tests in a single biopsy, avoiding secondary damage to the embryo.
Does PGT testing harm the embryo?
At RSMC, we only perform biopsies on blastocysts (day 5-7). We extract a few cells from the trophectoderm (which becomes the placenta), not the inner cell mass. With our 92.2% recovery rate, your embryos are extremely safe.
In summary, PGT-A and PGT-M are the two cornerstones of modern reproductive medicine. Whether you are looking for the best genes or need precise genetic diagnosis, RSMC provides professional support. In 2026, utilizing these advanced technologies is a scientific guarantee for family happiness.